Dashboard
Manage Tickers

MNKD MANNKIND CORP

Nasdaq mannkindcorp.com


$ 5.59 $ 0.04 (0.72 %)    

Friday, 31-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 5.59
$ 5.51
$ 5.31 x 288
$ 5.70 x 2
$ 5.46 - $ 5.66
$ 3.38 - $ 7.63
3,411,412
na
1.72B
$ 1.17
$ 52.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fda-accepts-for-review-mannkinds-supplemental-biologics-license-application-for-inhaled-insulin-in-children-4-17-years
FDA Accepts For Review MannKind's Suppleme...
10/13/2025 12:10:02

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
10/13/2025 11:12:42

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $11 price target.

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
09/18/2025 10:17:42

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $11 price target.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/09/2025 17:35:29

oppenheimer-maintains-outperform-on-mannkind-raises-price-target-to-15
Oppenheimer Maintains Outperform on MannKi...
09/05/2025 14:31:27

Oppenheimer analyst Andreas Argyrides maintains MannKind (NASDAQ:MNKD) with a Outperform and raises the price target from $1...

wells-fargo-maintains-overweight-on-mannkind-raises-price-target-to-10
Wells Fargo Maintains Overweight on MannKi...
09/03/2025 12:58:45

Wells Fargo analyst Tiago Fauth maintains MannKind (NASDAQ:MNKD) with a Overweight and raises the price target from $9 to $10.

hc-wainwright--co-maintains-buy-on-mannkind-raises-price-target-to-11
HC Wainwright & Co. Maintains Buy on MannK...
09/02/2025 16:16:43

HC Wainwright & Co. analyst Brandon Folkes maintains MannKind (NASDAQ:MNKD) with a Buy and raises the price target from ...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 12:08:23

Core News & Articles
United Therapeutics Expands MannKind Deal ...
08/27/2025 12:08:54

 MannKind Corporation (NASDAQ:MNKD) today announced that United Therapeutics Corporation (NASDAQ:UTHR) has exercised its option...

rbc-capital-maintains-outperform-on-mannkind-raises-price-target-to-8
RBC Capital Maintains Outperform on MannKi...
08/26/2025 14:21:58

RBC Capital analyst Douglas Miehm maintains MannKind (NASDAQ:MNKD) with a Outperform and raises the price target from $7 to $8.

mannkind-backed-by-blackstone-expands-cardiorenal-focus-with-360-million-deal
MannKind, Backed By Blackstone, Expands Ca...
08/25/2025 17:57:32

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a ...

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
08/25/2025 17:54:17

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $9 price target.

Core News & Articles
MannKind To Acquire scPharmaceuticals For ...
08/25/2025 11:33:57

rbc-capital-maintains-outperform-on-mannkind-lowers-price-target-to-7
RBC Capital Maintains Outperform on MannKi...
08/07/2025 15:06:29

RBC Capital analyst Douglas Miehm maintains MannKind (NASDAQ:MNKD) with a Outperform and lowers the price target from $8 to $7.

mannkind-q2-2025-adj-eps-005-inline-sales-76527m-miss-77521m-estimate
MannKind Q2 2025 Adj. EPS $0.05, Inline, S...
08/06/2025 12:07:10

mannkind-secures-up-to-500m-from-blackstone-to-fuel-afrezza-launch-and-pipeline-growth-without-diluting-shareholders
MannKind Secures Up to $500M From Blacksto...
08/06/2025 11:12:43

MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products ...

mannkind-and-blackstone-announced-an-500m-strategic-financing-agreement-the-financing-agreement-provides-mannkind-with-non-dilutive-capital-to-advance-its-short--and-long-term-growth-strategies
MannKind And Blackstone Announced An $500M...
08/06/2025 11:12:11

The up to $500 million senior secured credit facility consists of a $75 million initial term loan funded at closing, a $125 mil...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

a-look-ahead-mannkinds-earnings-forecast
A Look Ahead: MannKind's Earnings Forecast
08/05/2025 19:03:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION